Plausible prediction of renoprotective effects of sodium-glucose cotransporter-2 inhibitors in patients with chronic kidney diseases
AE Berezin, TA Berezina - Journal of International Medical …, 2024 - journals.sagepub.com
This narrative review was conducted due to uncertainty in predicting the beneficial impact of
sodium-glucose cotransporter-2 (SGLT2) inhibitors on a dip of estimated glomerular filtration …
sodium-glucose cotransporter-2 (SGLT2) inhibitors on a dip of estimated glomerular filtration …
Scientific evidence of sodium-glucose cotransporter-2 inhibitors for heart failure with preserved ejection fraction: an umbrella review of systematic reviews and meta …
R Li, G Dai, H Guan, W Gao, L Ren… - Frontiers in …, 2023 - frontiersin.org
Background It remains controversial whether sodium-glucose cotransporter-2 inhibitors
(SGLT-2is) are effective in treating heart failure with preserved ejection fraction (HFpEF) …
(SGLT-2is) are effective in treating heart failure with preserved ejection fraction (HFpEF) …
Long-term trajectory of renal dysfunction and related risk factors in patients with apparently treatment-resistant and non-resistant arterial hypertension
Z Ramík, J Václavík, T Kvapil, L Jelínek… - Blood …, 2024 - Taylor & Francis
Objectives: Evidence suggests that renal function increasingly deteriorates in patients with
apparently treatment-resistant hypertension (ATRH) in comparison with those who have non …
apparently treatment-resistant hypertension (ATRH) in comparison with those who have non …
Therapie des Typ-2-Diabetes
R Landgraf, J Aberle, AL Birkenfeld, B Gallwitz… - Die Diabetologie, 2024 - Springer
Die Praxisempfehlungen der Deutschen Diabetes Gesellschaft (DDG) lehnen sich an die
Inhalte der Nationalen Versorgungs-Leitlinie (NVL) Typ-2-Diabetes an [1]. Die in den …
Inhalte der Nationalen Versorgungs-Leitlinie (NVL) Typ-2-Diabetes an [1]. Die in den …
[PDF][PDF] Sodium–glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction: Treat the heart, cherish the kidney
G Voordes, K Damman - European Journal of Heart Failure, 2023 - research.rug.nl
We have known for decades that guideline-recommended medical treatments in heart
failure (HF) with reduced ejection fraction (HFrEF) often have an impact on kidney function. 1 …
failure (HF) with reduced ejection fraction (HFrEF) often have an impact on kidney function. 1 …
[HTML][HTML] Perils and Pitfalls With Associations in Heart Failure, Particularly in HF-pEF
PE Carson - JACC: Asia, 2023 - jacc.org
Heart failure (HF) is a major cause of morbidity and mortality worldwide. Diabetes mellitus
(DM) and chronic kidney disease (CKD) are also increasing on a worldwide basis. The …
(DM) and chronic kidney disease (CKD) are also increasing on a worldwide basis. The …
Earlier onset of treatment improves the nephroprotective effect of dapagliflozin
A Gippini, A Prado - Nefrología (English Edition), 2024 - revistanefrologia.com
Chronic kidney disease (CKD) is a common condition that is a major risk factor for cardio-
vascular events, end-stage renal disease and all-cause mortality. 1 In several large trials …
vascular events, end-stage renal disease and all-cause mortality. 1 In several large trials …
Efficacy and safety of SGLT2 inhibitors in nondiabetic patients with CKD: a review of recent evidence
J Lv, L Guo, R Wang, J Chen - Kidney Diseases, 2023 - karger.com
Abstract Background: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) were initially
developed as glucose-lowering agents in patients with type-2 diabetes. However, available …
developed as glucose-lowering agents in patients with type-2 diabetes. However, available …
Sodium glucose transporters inhibitors in the management of heart failure
RB Singh, S Chakravorty, O Elmaraghi… - … , Risk Factors, and …, 2024 - Elsevier
There is evidence that sodium-glucose co-transporter 2 (SGLT2) inhibitors, reduce heart
failure (HF) events and cardiovascular (CV) death in cohorts of HF, type 2 diabetes mellitus …
failure (HF) events and cardiovascular (CV) death in cohorts of HF, type 2 diabetes mellitus …
EFFECT OF GLIFLOZINS ON RENAL DYSFUNCTION IN CHRONIC HEART FAILURE WITH ANEMIA
AG Gadaev, FI Khujakulova - Oriental Journal of Medicine and …, 2023 - supportscience.uz
In the article, the effect of standard treatments containing gliflozin, ie glucose sodium
cotransporter type 2 inhibitor dapagliflozin-forsi, on kidney function in particular on …
cotransporter type 2 inhibitor dapagliflozin-forsi, on kidney function in particular on …